Deal opens doors to overseas markets with low competition
More than 2,500 BSV employees will be joining Mankind
Mankind Pharma rose as much as 1.2 per cent following Thursday's Bloomberg News report. The shares are up about 6.5 per cent this year and 10 per cent in the past 12 months
Advent International, the private equity firm currently owning BSV, appointed JP Morgan and Jefferies to facilitate the sale of the biopharma firm
The agreement allows Mankind Pharma to launch the novel drug for treating Gastroesophageal Reflux Disease
Mankind Pharma, the domestic pharmaceutical major's stock price surged up to 5.27 per cent at Rs 2,215 per share on the BSE in Wednesday's intraday trade
Stocks to watch on July 10: Emcure Pharmaceuticals' shares are scheduled to make their debut on the stock exchanges on Wednesday
Advent looking to exit 4 years after it picked up majority stake in biopharma firm
The drug maker was reportedly interested in buying private equity (PE) firm Advent International's stake in Mumbai-based biopharma firm Bharat Serums and Vaccines (BSV)
At 6:40 AM, GIFT Nifty futures were up by 90 points, trading at 22,377.50 levels compared to Nifty50 futures, indicating a gap-up opening for the stock exchanges
Mankind's revenue from operations rose to Rs 2,441 crore in Q4 FY24, an 18.9 per cent Y-o-Y rise from Rs 2,052 crore reported in Q4 FY23
Q4 FY24 company results: Dixon Technologies, Jindal Stainless, Power Finance Corporation, Thomas Cook will also release their financial results
Mankind Pharma's stock surged 3.11 per cent on BSE on Tuesday
As of May 13, 2024, India's weight in the MSCI Emerging Market Index stood at around 18 per cent, a considerable rise from approximately 8 per cent in early 2020
Nuvama has identified about a dozen "high conviction" domestic stocks that could get added to the index
Standard Chartered Bank is offering up to 7.5 million shares in Central Depository Services India (CDSL) in a placement
According to media reports, Beige Ltd, an affiliate of private equity firm ChrysCapital, was looking to offload 2.90 per cent stake in the drugmaker through block deals
Stocks to Watch on March 26, 2024: Reliance Industries acquired a 100 per cent stake in MSKVY Nineteenth Solar SPV and MSKVY Twenty-second Solar SPV from MSEB Solar Agro Power
Mankind Pharma, a pharmaceutical company in India, boasts a vast distribution network with over 16,000 field personnel and 13,000 stockists
AstraZeneca Pharma India Ltd and Mankind Pharma Ltd on Monday said they have entered into an agreement for exclusive distribution of the Symbicort brand, an asthma medicine, in India. Symbicort is owned by AstraZeneca, which will retain the intellectual property rights and will continue to be the marketing authorisation holder (MAH) and import license after the agreement, a joint statement shared on BSE by AstraZeneca Pharma India said. "The partnership with Mankind Pharma presents an opportunity to accelerate access and maximise the potential of our asthma drug as well as the turbuhaler which is a simple device, efficient in consistently delivering a higher proportion of respirable particles than the other devices," AstraZeneca India Managing Director and Country President Sanjeev Panchal said. Mankind Pharma has a distribution network, including close to 16,000 field forces and more than 13,000 stockists, across India providing access to quality pharmaceuticals across the country,